Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Mark Rubash Sells 1,000 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Mark Rubash sold 1,000 shares of the business’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $580.00, for a total value of $580,000.00. Following the completion of the sale, the director now owns 5,298 shares in the company, valued at $3,072,840. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

ISRG traded down $2.22 on Tuesday, hitting $579.28. 2,006 shares of the company were exchanged, compared to its average volume of 535,936. Intuitive Surgical, Inc. has a 12 month low of $430.24 and a 12 month high of $589.32. The company has a market cap of $65.82 billion, a PE ratio of 61.28, a PEG ratio of 4.27 and a beta of 1.12. The stock’s fifty day moving average is $550.63 and its 200-day moving average is $520.57.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.44. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. The business had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the company posted $2.83 earnings per share. Intuitive Surgical’s revenue was up 22.5% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 10.96 earnings per share for the current fiscal year.

A number of analysts have recently commented on the company. BidaskClub lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, September 11th. Wells Fargo & Co set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a report on Friday, October 18th. Morgan Stanley set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a report on Friday, October 18th. Piper Jaffray Companies set a $633.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, ValuEngine upgraded Intuitive Surgical from a “strong sell” rating to a “sell” rating in a report on Friday, November 8th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the stock. Intuitive Surgical currently has a consensus rating of “Buy” and a consensus price target of $587.62.

A number of large investors have recently added to or reduced their stakes in the business. Pinnacle Bank grew its holdings in Intuitive Surgical by 50.0% in the 2nd quarter. Pinnacle Bank now owns 135 shares of the medical equipment provider’s stock valued at $71,000 after buying an additional 45 shares during the last quarter. Burns J W & Co. Inc. NY grew its holdings in Intuitive Surgical by 28.2% in the 2nd quarter. Burns J W & Co. Inc. NY now owns 1,497 shares of the medical equipment provider’s stock valued at $785,000 after buying an additional 329 shares during the last quarter. Retirement Systems of Alabama grew its holdings in Intuitive Surgical by 1.0% in the 2nd quarter. Retirement Systems of Alabama now owns 53,837 shares of the medical equipment provider’s stock valued at $28,240,000 after buying an additional 526 shares during the last quarter. Spence Asset Management grew its holdings in Intuitive Surgical by 5.0% in the 2nd quarter. Spence Asset Management now owns 21,628 shares of the medical equipment provider’s stock valued at $11,345,000 after buying an additional 1,027 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC grew its holdings in Intuitive Surgical by 99.2% in the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 1,876 shares of the medical equipment provider’s stock valued at $984,000 after buying an additional 934 shares during the last quarter. Hedge funds and other institutional investors own 85.59% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Read More: How can you know how many shares are floating?

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.